Schering

By Kim S. Nash  |  Posted 2002-07-10 Email Print this article Print
 
 
 
 
 
 
 

Jarred by a $500 million judgment, drugmaker Schering-Plough is racing to comply with government regulations. Will technology slow it down?

-Plough Base Case">

Schering-Plough Base Case

Headquarters: 2000 Galloping Hill Rd., Kenilworth, NJ 07033

Phone: (908) 298-4000

Business: Pharmaceutical and health care products

Chief Information Officer: Donald Lemma

Financials in 2001: $9.8 billion in sales, $2.9 billion operating income, $1.9 billion net income

Challenge: To fix chronic manufacturing problems that led to a $500 million fine by the Food and Drug Administration

Baseline Goals:

  • Increase return on equity, from 3% in 2001. It had been 43% in 2000.
  • Submit plans for fixing manufacturing problems by Sept. 17 to Food and Drug Administration
  • Stop receiving FDA warning letters by 2005, down from 34 from 1997 through 2001


  • <12
     
     
     
     
    Senior Writer
    Kim_Nash@ziffdavisenterprise.com
    Kim has covered the business of technology for 14 years, doing investigative work and writing about legal issues in the industry, including Microsoft Corp.'s antitrust trial. She has won numerous awards and has a B.S. degree in journalism from Boston University.
     
     
     
     
     
     

    Submit a Comment

    Loading Comments...
    Manage your Newsletters: Login   Register My Newsletters